NASDAQ:INMB - INmune Bio Price Target & Analyst Ratings

$9.35
+0.14 (+1.52 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$8.7353
Now: $9.35
$9.6042
50-Day Range
$8.81
MA: $9.92
$10.50
52-Week Range
$7.00
Now: $9.35
$11.50
Volume8,132 shs
Average Volume8,758 shs
Market Capitalization$96.87 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

INmune Bio (NASDAQ:INMB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for INmune Bio in the last 12 months. Their average twelve-month price target is $13.00, suggesting that the stock has a possible upside of 39.04%. The high price target for INMB is $13.00 and the low price target for INMB is $13.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $13.00$13.00$13.00N/A
Price Target Upside: 39.04% upside22.53% upside68.18% upsideN/A

INmune Bio (NASDAQ:INMB) Consensus Price Target History

INmune Bio (NASDAQ:INMB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/10/2019Maxim GroupSet Price TargetBuy$13.00HighView Rating Details
(Data available from 7/20/2017 forward)
This page was last updated on 7/20/2019 by MarketBeat.com Staff

Featured Article: What is the QQQ ETF?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel